Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Reaume MN, Basappa NS, Wood L, Kapoor A, Bjarnason GA, Blais N, Breau RH, Canil C, Cheung P, Conter HJ, Hotte SJ, Jeldres C, Jewett MAS, Karakiewicz PI, Kollmannsberger C, Patenaude F, So A, Soulières D, Venner P, Violette P, Zalewski P, Chappell H, North SA; Kidney Cancer Research Network of Canada. Reaume MN, et al. Among authors: kapoor a. Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769. Can Urol Assoc J. 2017. PMID: 29382441 Free PMC article. No abstract available.
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Bjarnason GA, Knox JJ, Kollmannsberger CK, Soulieres D, Ernst DS, Zalewski P, Canil CM, Winquist E, Hotte SJ, North SA, Heng DYC, Macfarlane RJ, Venner PM, Kapoor A, Hansen AR, Eigl BJ, Czaykowski P, Boyd B, Wang L, Basappa NS. Bjarnason GA, et al. Among authors: kapoor a. Eur J Cancer. 2019 Feb;108:69-77. doi: 10.1016/j.ejca.2018.12.006. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30648632 Free article. Clinical Trial.
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN. Saad F, et al. Among authors: kapoor a. Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136. Can Urol Assoc J. 2019. PMID: 31603409 Free PMC article. No abstract available.
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
Cheng S, Arciero V, Goldberg H, Tajzler C, Manganaro A, Kozlowski N, Rowbottom L, McDonald R, Chow R, Vasisht G, Shaji S, Wong ECL, Petrovic M, Zhang L, Phillips C, Zalewski P, Kapoor A, Fleshner NE, Chow E, Emmenegger U. Cheng S, et al. Among authors: kapoor a. Cancer Manag Res. 2019 Oct 31;11:9307-9319. doi: 10.2147/CMAR.S213051. eCollection 2019. Cancer Manag Res. 2019. PMID: 31802949 Free PMC article.
Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer.
So AI, Chi KN, Danielson B, Fleshner NE, Kapoor A, Niazi T, Pouliot F, Rendon RA, Shayegan B, Sridhar S, Vigneault E, Saad F. So AI, et al. Among authors: kapoor a. Can Urol Assoc J. 2020 Feb;14(2):17-23. doi: 10.5489/cuaj.6384. Epub 2019 Dec 5. Can Urol Assoc J. 2020. PMID: 31999544 Free PMC article. No abstract available.
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists.
Hotte SJ, Finelli A, Chi KN, Canil C, Fleshner N, Kapoor A, Kolinsky M, Malone S, Morash C, Niazi T, Noonan KL, Ong M, Pouliot F, Shayegan B, So AI, Sorabji D, Hew H, Park-Wyllie L, Saad F. Hotte SJ, et al. Among authors: kapoor a. Can Urol Assoc J. 2021 Feb;15(2):E90-E96. doi: 10.5489/cuaj.6779. Can Urol Assoc J. 2021. PMID: 32853135 Free PMC article.
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN. Saad F, et al. Among authors: kapoor a. Can Urol Assoc J. 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074. Can Urol Assoc J. 2021. PMID: 33556313 Free PMC article. No abstract available.
2,109 results